Norris Medicines Ltd
Incorporated in 1990, Norris Medicines Ltd manufacturers Injections and Medicinal formulations
- Market Cap ₹ 16.6 Cr.
- Current Price ₹ 16.6
- High / Low ₹ 27.7 / 10.7
- Stock P/E
- Book Value ₹ -14.4
- Dividend Yield 0.00 %
- ROCE -8.43 %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -19.1% over past five years.
- Promoter holding is low: 34.0%
- Debtor days have increased from 52.9 to 68.6 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
20.70 | 18.68 | 18.86 | 20.46 | 13.57 | 16.26 | 7.84 | 12.25 | 9.44 | 8.36 | 5.64 | 4.59 | |
21.76 | 16.97 | 18.03 | 20.46 | 15.49 | 16.87 | 10.00 | 14.00 | 9.52 | 7.43 | 5.81 | 4.45 | |
Operating Profit | -1.06 | 1.71 | 0.83 | 0.00 | -1.92 | -0.61 | -2.16 | -1.75 | -0.08 | 0.93 | -0.17 | 0.14 |
OPM % | -5.12% | 9.15% | 4.40% | 0.00% | -14.15% | -3.75% | -27.55% | -14.29% | -0.85% | 11.12% | -3.01% | 3.05% |
0.12 | 0.15 | 0.30 | 0.06 | 0.14 | 0.04 | 0.09 | 0.05 | 0.03 | 0.01 | 0.01 | 0.04 | |
Interest | 0.45 | 0.54 | 0.67 | 0.60 | 0.70 | 0.73 | 0.88 | 1.63 | 1.48 | 1.50 | 0.37 | 0.39 |
Depreciation | 1.17 | 1.31 | 0.60 | 0.65 | 0.71 | 0.71 | 0.73 | 0.67 | 0.66 | 0.63 | 0.57 | 0.53 |
Profit before tax | -2.56 | 0.01 | -0.14 | -1.19 | -3.19 | -2.01 | -3.68 | -4.00 | -2.19 | -1.19 | -1.10 | -0.74 |
Tax % | -42.97% | 10,500.00% | -128.57% | -35.29% | -21.00% | -16.42% | -22.83% | 24.25% | 49.32% | 47.06% | 8.18% | |
-1.45 | -1.04 | 0.04 | -0.77 | -2.51 | -1.68 | -2.84 | -4.96 | -3.26 | -1.75 | -1.19 | -0.84 | |
EPS in Rs | -1.45 | -1.04 | 0.04 | -0.77 | -2.51 | -1.68 | -2.84 | -4.96 | -3.26 | -1.75 | -1.19 | -0.84 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | -12% |
5 Years: | -19% |
3 Years: | -23% |
TTM: | -15% |
Compounded Profit Growth | |
---|---|
10 Years: | 2% |
5 Years: | 5% |
3 Years: | 21% |
TTM: | 56% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 44% |
3 Years: | -22% |
1 Year: | 26% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 9.93 | 9.93 | 9.93 | 9.93 | 9.93 | 9.93 | 9.93 | 9.93 | 9.93 | 9.93 | 9.93 | 9.93 |
Reserves | -3.58 | -4.63 | -4.60 | -5.36 | -7.88 | -9.55 | -12.39 | -17.36 | -20.62 | -22.37 | -23.56 | -24.28 |
7.52 | 8.16 | 7.51 | 7.57 | 7.71 | 11.24 | 17.92 | 15.52 | 21.08 | 21.40 | 21.52 | 21.58 | |
7.45 | 4.69 | 5.06 | 9.90 | 10.92 | 8.76 | 5.10 | 11.69 | 3.80 | 4.72 | 6.29 | 5.75 | |
Total Liabilities | 21.32 | 18.15 | 17.90 | 22.04 | 20.68 | 20.38 | 20.56 | 19.78 | 14.19 | 13.68 | 14.18 | 12.98 |
8.97 | 8.61 | 8.34 | 9.97 | 9.32 | 8.90 | 8.25 | 7.67 | 7.07 | 6.47 | 5.79 | 5.54 | |
CWIP | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
12.24 | 9.53 | 9.55 | 12.06 | 11.35 | 11.47 | 12.30 | 12.10 | 7.11 | 7.20 | 8.38 | 7.43 | |
Total Assets | 21.32 | 18.15 | 17.90 | 22.04 | 20.68 | 20.38 | 20.56 | 19.78 | 14.19 | 13.68 | 14.18 | 12.98 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|
1.44 | -1.43 | 1.35 | -0.96 | 0.80 | -1.92 | -2.88 | 1.11 | -1.01 | 1.20 | 0.17 | |
-1.75 | -0.88 | -0.34 | -2.05 | -0.08 | -0.29 | 0.00 | -0.06 | -0.09 | -0.02 | 0.05 | |
0.02 | 0.10 | -1.32 | 3.16 | -0.66 | 2.18 | 2.86 | -1.09 | 1.10 | -1.18 | -0.20 | |
Net Cash Flow | -0.28 | -2.21 | -0.31 | 0.15 | 0.06 | -0.02 | -0.02 | -0.04 | 0.00 | 0.00 | 0.02 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 91.34 | 73.66 | 53.61 | 84.20 | 66.44 | 67.57 | 128.49 | 53.33 | 42.15 | 48.03 | 68.60 |
Inventory Days | 74.17 | 100.05 | 134.23 | 129.50 | 238.53 | 134.81 | 323.82 | 212.99 | 157.45 | 347.62 | 594.15 |
Days Payable | 151.02 | 111.66 | 99.30 | 125.29 | 252.40 | 139.83 | 233.37 | 218.83 | 86.53 | 149.91 | 244.25 |
Cash Conversion Cycle | 14.50 | 62.06 | 88.54 | 88.41 | 52.56 | 62.55 | 218.94 | 47.49 | 113.06 | 245.73 | 418.51 |
Working Capital Days | 16.22 | 40.84 | 35.22 | -16.06 | -91.18 | -32.55 | -30.73 | -103.69 | 17.40 | 7.86 | -12.94 |
ROCE % | 4.02% | 4.03% | -4.08% | -22.92% | -11.97% | -20.68% | -20.13% | -7.68% | 3.20% | -8.43% |
Documents
Announcements
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 4 Apr
-
Closure of Trading Window
29 Mar - Closure of trading window until financial results are declared.
-
Integrated Filing (Financial)
14 Feb - Board approved unaudited financial results for Q3 2024.
- Outcome Of Board Meeting Held On 13Th February, 2025 Pursuant To Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015. 13 Feb
-
Board Meeting Outcome for Outcome Of Board Meeting Dated (Board Meeting Date) Pursuant To Regulation 30 And 31A (8) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
13 Feb - Approval of financial results and reclassification request.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2000
from bse
-
Financial Year 1998
from bse
Business Overview:[1]
Company is in Health Care Industry and does contract manufacturing and Loan License Manufacturing for pharma companies.